Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response

Anamika Patel; Sanjeev Kumar; Lilin Lai; Chennareddy Chakravarthy; Rajesh Valanparambil; Elluri Seetharami Reddy; Kamalvishnu Gottimukkala; Prashant Bajpai; Dinesh Ravindra Raju; Venkata Vishwanadh Edara; Meredith E Davis-Gardner; Susi Linderman; Kritika Dixit; Pragati Sharma; Grace Mantus; Narayanaiah Cheedarla; Hans P. Verkerke; Filipp Frank; Andrew S. Neish; John D. Roback; Carl W. Davis; Jens Wrammert; Rafi Ahmed; Mehul Suthar; Amit Sharma; Kaja Murali-Krishna; Anmol Chandele; Eric A. Ortlund.
Preprint en Inglés | PREPRINT-BIORXIV | ID: ppbiorxiv-513517

Documentos relacionados

  1. Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response.
  2. A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern.
  3. Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infection.
  4. The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2.
  5. Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response.
  6. Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
  7. Deep mutational scanning identifies SARS-CoV-2 Nucleocapsid escape mutations of currently available rapid antigen tests.
  8. A panel of multivalent nanobodies broadly neutralizing Omicron subvariants and recombinant.
  9. Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2.
  10. Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.